Cannon said it was satisfying in June to get a U.S. Supreme Court decision backing the position his client, Roche Molecular Systems Inc., took against Stanford University from the beginning of a closely watched patent case more than five years ago. Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems Inc., 09-1159.
The court said in a 7-2 decision that the Bayh-Dole Act, a law that promotes the commercialization...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In